Background: Colorectal adenomas are the usual precursors to carcinoma in sporadic and hereditary colorectal cancers (CRC).
Methods: A total of 220 CRC patients (stages 0, I, and II) were randomized prospectively in a double-blind pilot study of calcium chemoprevention by using recurrent colorectal adenomas as a surrogate end point. This trial is still in progress, and we report the preliminary findings on adenoma recurrence rates.
Results: Synchronous adenomas were present in 60% of patients, and cancer confined in a polyp was present in 23% of patients. The overall cumulative adenoma recurrence rate was 31% (19% in the first year, 29% for 2 years, and 35% for 3 years). The recurrence rates were greater for patients with synchronous adenomas: 38% at 3 years (P = .01). Lower stage was associated with higher adenoma recurrence rates (P = .04). Factors including age, sex, site of primary cancer, and whether the cancer was confined to a polyp were not significantly associated with differences in adenoma recurrence rates.
Conclusions: The substantial adenoma recurrence rate in patients resected of CRC justifies colonoscopic surveillance on a periodic basis. Patients with higher rates of adenoma recurrences, such as CRC with synchronous adenomas, are ideal subjects for chemoprevention trials.
Adenoma Colorectal cancer Synchronous adenoma Adenoma recurrence rate
Thiis-Eversen E, Hoff GS, Sauar J, Langmark F, Majak BM, Batn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414–20.CrossRefGoogle Scholar
Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658–62.PubMedCrossRefGoogle Scholar
Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Work group. N Engl J Med 1993;329:1977–81.PubMedCrossRefGoogle Scholar
Chu DZJ, Giacco G, Martin RC, Guinee VF. The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer 1986;57:445–50.PubMedCrossRefGoogle Scholar
Neugut AI, Lautenbach E, Abi-Rached B, Forde KA. Incidence of adenomas after curative resection for colorectal cancer. Am J Gastroenterol 1996;91:2096–8.PubMedGoogle Scholar
Khoury DA, Opelka FG, Beck DE, Hicks TC, Timmcke AE, Gathright JB. Colon surveillance after colorectal cancer surgery. Dis Colon Rectum 1996;39:252–6.PubMedCrossRefGoogle Scholar
Patchett SE, Mulcahy HE, O’Donoghue DP. Colonoscopic surveillance after curative resection for colorectal cancer. Br J Surg 1993;80:1330–2.PubMedCrossRefGoogle Scholar
Barlow AP, Thompson MH. Colonoscopic follow-up after resection for colorectal cancer: a selective policy. Br J Surg 1993;80:781–4.PubMedCrossRefGoogle Scholar
Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101–7.PubMedCrossRefGoogle Scholar
Steinbach G, Lynch PM, Phillips RKS, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946–52.PubMedCrossRefGoogle Scholar
Baron JA, Cole BF, Mott LA. Aspirin chemoprevention of colorectal adenomas. Proc Am Assoc Cancer Res 2002;43:669.Google Scholar
Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001;120:1077–83.PubMedCrossRefGoogle Scholar
Yang G, Zheng W, Sun QR, et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 1998;90:1661–5.PubMedCrossRefGoogle Scholar
Jensen P, Krosgsgaard MR, Christiansen J. Prognostic model for patients treated for colorectal adenomas with regard to development of recurrent adenomas and carcinoma. Eur J Surg 1996;162:229–34.PubMedGoogle Scholar
Nusko G, Mansmann U, Wiest G, Brueckl W, Kirchner T, Hahn EG. Right-sided shift found in metachronous colorectal adenomas. Endoscopy 2001;33:574–9.PubMedCrossRefGoogle Scholar
Slater G, Fleshner P, Aufses AH. Colorectal cancer location and synchronous adenomas. Am J Gastroenterol 1988;83:832–6.PubMedGoogle Scholar
Cuquerella J, Orti E, Canelles P, et al. Colonoscopic follow-up of patients undergoing curative resection of colorectal cancer (in Spanish). Gastroenterol Hepatol 2001;24:415–20.PubMedGoogle Scholar
Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg 1984;147:330–3.PubMedCrossRefGoogle Scholar
Scorza R, De Monti M, Ghilardi G, Sgroi G, Kunkl E. Endoscopy and surgery. A combined strategy for diagnosis and therapy of polyposis-cancer sequence in the colon. Panminerva Med 2001;43:21–6.PubMedGoogle Scholar
Jensen P, Krogsgaard MR, Christiansen J. Prognostic model for patients treated for colorectal adenomas with regard to development of recurrent adenomas and carcinoma. Eur J Surg 1996;162:229–34.PubMedGoogle Scholar
Togashi K, Knonishi F, Ozawa A, et al. Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis colon Rectum 2000;43(Suppl):S47–53.PubMedCrossRefGoogle Scholar
Shureiqi I, Cooksley CD, Morris J, Soliman AS, Levin B, Lippman SM. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst 2001;93:1264–6.PubMedCrossRefGoogle Scholar
Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of intergroup 0089. Ann Intern Med 2002;136:261–9.PubMedGoogle Scholar